New Zealand markets closed

Fortress Biotech, Inc. (FBIO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.72000.0000 (0.00%)
At close: 04:00PM EDT
1.7000 -0.02 (-1.16%)
After hours: 04:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 33.08M
Enterprise value 36.82M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.17
Price/book (mrq)1.47
Enterprise value/revenue 0.44
Enterprise value/EBITDA -0.28

Trading information

Stock price history

Beta (5Y monthly) 1.53
52-week change 3-85.30%
S&P500 52-week change 322.36%
52-week high 311.8500
52-week low 31.2400
50-day moving average 31.9166
200-day moving average 33.4929

Share statistics

Avg vol (3-month) 3290.93k
Avg vol (10-day) 3217.07k
Shares outstanding 519.23M
Implied shares outstanding 619.23M
Float 814.26M
% held by insiders 126.31%
% held by institutions 124.48%
Shares short (15 Apr 2024) 41.82M
Short ratio (15 Apr 2024) 46.48
Short % of float (15 Apr 2024) 412.58%
Short % of shares outstanding (15 Apr 2024) 49.47%
Shares short (prior month 15 Mar 2024) 41.73M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 310 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -71.75%
Operating margin (ttm)-1.58%

Management effectiveness

Return on assets (ttm)-37.68%
Return on equity (ttm)-597.36%

Income statement

Revenue (ttm)84.51M
Revenue per share (ttm)10.42
Quarterly revenue growth (yoy)137.40%
Gross profit (ttm)N/A
EBITDA -133.2M
Net income avi to common (ttm)-68.67M
Diluted EPS (ttm)-8.4700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)80.93M
Total cash per share (mrq)4.21
Total debt (mrq)88.59M
Total debt/equity (mrq)5,582.36%
Current ratio (mrq)1.38
Book value per share (mrq)1.49

Cash flow statement

Operating cash flow (ttm)-128.22M
Levered free cash flow (ttm)-100.12M